<DOC>
	<DOCNO>NCT01052753</DOCNO>
	<brief_summary>The ultimate goal study find specific polymorphism candidate gene ( particularly dopaminergic noradrenergic system ) associate intermediate phenotype ( e.g. , executive function , IQ , neuropsychological function ) and/or phenomenological phenotype ( subtypes , comorbidity , dimensional approach ) ADHD . We propose replicate analysis candidate gene identify previous genetic study recent finding GWAS ADHD use candidate gene association study design ( family-based case control study use parental control population-based case-control study ) . These result may lead research team : ( 1 ) resolve controversy inconsistent finding previous genetic study contribute literature validity ADHD subtypes use clinical genetic data ; ( 2 ) identify potential endophenotypes ADHD genetic study ; ( 3 ) identify specific polymorphism candidate gene gene expression dopaminergic noradrenergic system associate executive function measure CANTAB .</brief_summary>
	<brief_title>The Association Between Executive Functions Candidate Genes Dopaminergic Noradrenergic Systems Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>Attention deficit hyperactivity disorder ( ADHD ) common , impairing , highly heritable , clinically heterogeneous early-onset neuropsychiatric disorder . Despite substantial evidence support genetic etiology ADHD , molecular genetic study far yet provide conclusive result use categorical subgroup approach phenotype . Hence , grow interest use endophenotypes molecular genetic study ADHD . Our previous study demonstrate significant deficit executive function among child ADHD efficacy methylphenidate atomoxetine , involve dopaminergic noradrenergic system , reduce ADHD core symptom improve executive function . In longitudinal follow-up family study ADHD , also report executive dysfunction measure Cambridge Neuropsychological Test Automated Batteries ( CANTAB ) potential endophenotypes ADHD . Hence , identify specific polymorphism candidate gene dopaminergic noradrenergic system associate executive dysfunction Han Chinese Taiwan warrant . Specific Aims : 1 . To identify specific genetic polymorphism candidate gene dopaminergic noradrenergic system ( e.g. , DRD2 , DRD4 , DRD5 , DAT1 , NET , ADRA2A , DBH , COMT etc . ) associate executive dysfunction measure CANTAB alternative phenotype approach ( ADHD subtypes , comorbidities , treatment effect , IQ , symptom dimension severity ) ; 2. investigate relationship variety ADHD phenotypes endophenotypes gene expression DRD2 , DAT1 , NET , ADRA2A , DBH , COMT ; 3. validate executive function search neuropsychological functioning endophenotypes ADHD ; 4. determine whether ADHD familial identify core symptom ADHD component neuropsychological functioning familial ; Subjects Methods : The major study design family-based case-control candidate gene association study . We recruit 150 probands ADHD , age 7-18 , parent ( n = 300 ) sibling ( n= 150 ) 150 school control three year ( 50 , 60 , 40 family ADHD 50 , 60 , 40 school control 1st , 2nd , 3rd year , respectively ) . The measure include ( 1 ) interview psychopathology ( K-SADS-E ) social functioning ( SAICA ) , ( 2 ) self-administered questionnaire measure ADHD symptom ( CPRS-R : S , CTRS-R : S , SNAP-IV Adult ADHD rating scale ) comorbid condition ( ASRI CBCL ) , ( 3 ) neuropsychological test : WISC-III-R , CPT , CANTAB , Time Perception Tasks . The transmission/disequilibrium test ( TDT ) quantitative TDT use FBAT FBAT-GEE , GEE , Mixed Models use data analysis . Anticipated Results : We anticipate establishment clinical , neuropsychological , genetic database least 350 family ( 150 family project ) 150 same-age control , completion genetic analysis gene expression several candidate gene include involve dopaminergic noradrenergic system , identification genetic variant ADHD diagnosis , symptom , comorbidities , executive function , neurocognitive endophenotypes Taiwanese sample . The finding different approach identify genetic etiology ADHD study help u determine promise approach future molecular genetic study ADHD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>The inclusion criterion proband subject ( 1 ) subject clinical diagnosis ADHD , Hyperkinetic Disorder ( HD ) define DSMIV ICD10 , respectively , make fulltime boardcertificated child psychiatrist first visit follow visit ; ( 2 ) age range 7 18 conduct study ; ( 3 ) subject able perform CANAB time test ; ( 4 ) subject ' IQ great 80 ; ( 5 ) subject biological parent ; ( 6 ) parent Han Chinese ; ( 7 ) subject biological parent ( sibling ) consent participate study complete phenotype assessment blood data collection . The inclusion criterion control subject ( 1 ) subject diagnosis ADHD , Hyperkinetic Disorder ( HD ) define DSMIV ICD10 , respectively , past current assessment ; ( 2 ) subject able perform CANAB time test ; ( 4 ) subject ' IQ great 80 ; ( 5 ) subject Han Chinese ; ( 6 ) subject mother consent participate study complete phenotype assessment . The proband subject exclude study currently meet criterion history follow condition define DSMIV : Schizophrenia , Schizoaffective Disorder , Organic Psychosis , Pervasive Developmental Disorder . Moreover , subject also exclude study completely cooperate blood withdrawal neuropsychological assessment . The control subject exclude study currently meet criterion history follow condition define DSMIV : Schizophrenia , Schizoaffective Disorder , Organic Psychosis , Pervasive Developmental Disorder . Moreover , subject also exclude study completely cooperate neuropsychological assessment .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Attention-deficit/hyperactivity disorder</keyword>
	<keyword>executive function</keyword>
	<keyword>endophenotype</keyword>
	<keyword>dopaminergic system</keyword>
	<keyword>noradrenergic system</keyword>
	<keyword>candidate gene</keyword>
	<keyword>Family-based association study</keyword>
</DOC>